 |
市場調査レポート
商品コード
1375922
マルチオミクス市場規模、シェア、動向分析レポート：製品・サービス別、タイプ別、プラットフォーム別、最終用途別、地域別、セグメント予測、2023年～2030年Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| マルチオミクス市場規模、シェア、動向分析レポート：製品・サービス別、タイプ別、プラットフォーム別、最終用途別、地域別、セグメント予測、2023年～2030年 |
|
出版日: 2023年10月12日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
マルチオミクス市場の成長と動向：
Grand View Research, Inc.の最新レポートによると、世界のマルチオミクス市場規模は、2023年から2030年にかけて15.3%のCAGRを記録し、2030年までに63億8,000万米ドルに達すると予測されています。
オミックス技術のコスト低下や、民間および公的機関からの投資や資金調達の増加といった要因が市場を牽引すると見られています。また、製薬会社やバイオテクノロジー企業、学術研究機関からの需要増加による市場競争の激化も、予測期間中の市場成長を促進すると予測されています。
技術の向上により、オミックス技術のコストは低下し、研究者がデータセットにアクセスしやすくなり、結果的に市場成長を促進すると予想されます。企業はコスト削減のために技術の進歩に注力しています。例えば、アマゾン・ウェブ・サービスは2022年11月にアマゾン・オミックス・サービスを発表しました。このサービスは、バイオインフォマティクスを考慮したストレージオプションを利用して生のシーケンスデータを保存し、コストを削減します。このように、コストが低下することで、研究者や臨床医がオミックス技術にアクセスしやすくなると予想されます。このようなコスト削減は、マルチオミクス・アプローチの採用を増加させると予想されます。
民間および公的参加者からの投資や資金提供の増加は、マルチオミクス製品やサービスの需要を押し上げると予想されます。様々な企業がマルチオミクスのプラットフォームや技術の開発に多額の投資を行っています。例えば、2022年1月、ロシュはバイオテクノロジー企業であるFreenomeに2億9,000万米ドルを投資しました。この投資は、早期がん発見のためのマルチオミクス・プラットフォームを加速させるために使われました。さらに、2023年5月には、MultiOmic Health社が精密治療薬発見プラットフォーム構築のために620万米ドルの資金調達を完了しました。このように、新興国市場では、資金調達や投資の増加により、さまざまな新規プラットフォームや製品が開発されることが期待されています。
市場関係者が革新的な製品やサービスの開発に重点を置くようになっていることも、市場の需要を前進させる重要な要因です。さまざまな企業が、競争の激化に対応するため、斬新なプラットフォームを開発しています。例えば、2023年2月、Via Scientific, Inc.は、マルチオミクス研究中の複雑なデータと分析作業の自動化をサポートするマルチオミクスアクセラレータプラットフォーム、Foundryを発表しました。このような製品発表は、予測期間中、業界を牽引すると予想されます。
マルチオミクス市場レポートハイライト
- 製品・サービス別では、製品分野が2022年の売上高シェア60.5%で市場を独占しており、これは機器やソフトウェアなどの製品の発売が増加していることに起因しています。
- タイプ別では、バルクマルチオミクスが業界最大の収益貢献者でした。一方、シングルセルマルチオミクスは、複雑な生物学システムを理解するためのシングルセルマルチオミクスの需要増加により、予測期間中17.8%のCAGRで最速の成長が見込まれています。
- プラットフォーム別では、ゲノミクスが2022年の売上シェア40.6%で市場を独占しています。この成長は、このセグメントで利用可能な製品数が多いことに起因しています。
- 用途別では、細胞生物学分野が2022年に38.8%のシェアを占め、世界の業界を席巻しました。対照的に、腫瘍学セグメントは予測期間中に最も高い成長率を記録すると予測されています。
- 最終用途別では、学術・研究機関セグメントが50.7％のシェアで業界最大の収益貢献者でした。これとは対照的に、製薬会社やバイオテクノロジー会社は、創薬や薬剤開発を加速するためのマルチオミクスに対する需要の増加により、最も速い成長が見込まれています。
- 北米は2022年、48.45%の収益シェアで世界の業界を支配したが、これは同地域に主要な市場プレーヤーが存在するためです。
目次
第1章 調査手法と範囲
第2章 エグゼクティブサマリー
第3章 市場変数、動向、および範囲
- 市場系統の見通し
- 市場力学
- 業界分析ツール
第4章 製品およびサービスのビジネス分析
- マルチオミクス市場：製品およびサービスの変動分析
- 製品
- 製品市場、2018～2030年
- 楽器
- 消耗品
- ソフトウェア
- サービス
- サービス市場、2018～2030年
第5章 タイプビジネス分析
- マルチオミクス市場：タイプ変動分析
- 単細胞マルチオミクス
- バルクマルチオミクス
第6章 プラットフォームビジネス分析
- マルチオミクス市場：プラットフォームの変動分析
- ゲノミクス
- ゲノミクス市場、2018～2030年
- トランスクリプトミクス
- トランスクリプトミクス市場、2018～2030年
- プロテオミクス
- プロテオミクス市場、2018～2030年
- メタボロミクス
- メタボロミクス市場、2018～2030年
- 統合されたオミックスプラットフォーム
- 統合オミクスプラットフォーム市場、2018年から2030年
第7章 アプリケーションビジネス分析
- マルチオミクス市場：アプリケーションの変動分析
- 細胞生物学
- 腫瘍学
- 神経内科
- 免疫学
第8章 最終用途ビジネス分析
- マルチオミクス市場： 最終用途の変動分析
- 学術調査機関
- 学術調査機関市場、2018年から2030年
- 製薬およびバイオテクノロジー企業
- 製薬およびバイオテクノロジー企業市場、2018年から2030年
- その他
- その他市場、2018-2030
第9章 地域ビジネス分析
- 地域別マルチオミクス市場シェア、2022年および2030年
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ
第10章 競合情勢
- 企業の分類
- 戦略マッピング
- 企業の市況分析、2022年
- 企業プロファイル・一覧表
- BD
- Thermo Fisher Scientific, Inc,
- Illumina
- Danaher
- PerkinElmer
- Shimadzu Corporation
- Bruker
- QIAGEN
- Agilent Technologies
- BGI
図表
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 4 Global Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 5 Global Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 6 Global Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 7 Global Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 8 Global Multiomics Market, By Region, 2018 - 2030 (USD Million)
- Table 9 North America Multiomics Market, By Country, 2018 - 2030 (USD Million)
- Table 10 North America Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 11 North America Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 12 North America Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 13 North America Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 14 North America Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 15 U.S. Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 16 U.S. Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 17 U.S. Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 18 U.S. Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 19 U.S. Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 20 Canada Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 21 Canada Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 22 Canada Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 23 Canada Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 24 Canada Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 25 Europe Multiomics Market, By Country, 2018 - 2030 (USD Million)
- Table 26 Europe Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 27 Europe Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 28 Europe Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 29 Europe Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 30 Europe Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 31 UK Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 32 UK Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 33 UK Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 34 UK Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 35 UK Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 36 Germany Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 37 Germany Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 38 Germany Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 39 Germany Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 40 Germany Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 41 France Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 42 France Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 43 France Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 44 France Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 45 France Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 46 Spain Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 47 Spain Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 48 Spain Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 49 Spain Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 50 Spain Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 51 Italy Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 52 Italy Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 53 Italy Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 54 Italy Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 55 Italy Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 56 Denmark Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 57 Denmark Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 58 Denmark Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 59 Denmark Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 60 Denmark Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 61 Norway Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 62 Norway Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 63 Norway Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 64 Norway Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 65 Norway Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 66 Sweden Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 67 Sweden Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 68 Sweden Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 69 Sweden Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 70 Sweden Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 71 Asia Pacific Multiomics Market, By Country, 2018 - 2030 (USD Million)
- Table 72 Asia Pacific Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 73 Asia Pacific Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 74 Asia Pacific Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 75 Asia Pacific Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 76 Asia Pacific Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 77 China Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 78 China Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 79 China Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 80 China Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 81 China Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 82 Japan Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 83 Japan Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 84 Japan Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 85 Japan Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 86 Japan Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 87 India Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 88 India Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 89 India Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 90 India Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 91 India Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 92 South Korea Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 93 South Korea Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 94 South Korea Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 95 South Korea Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 96 South Korea Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 97 Australia Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 98 Australia Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 99 Australia Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 100 Australia Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 101 Australia Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 102 Thailand Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 103 Thailand Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 104 Thailand Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 105 Thailand Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 106 Thailand Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 107 Latin America Multiomics Market, By Country, 2018 - 2030 (USD Million)
- Table 108 Latin America Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 109 Latin America Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 110 Latin America Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 111 Latin America Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 112 Latin America Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 113 Brazil Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 114 Brazil Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 115 Brazil Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 116 Brazil Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 117 Brazil Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 118 Mexico Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 119 Mexico Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 120 Mexico Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 121 Mexico Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 122 Mexico Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 123 Argentina Multiomics Market, By Product & Service, 2018 - 2030 (USD Million),
- Table 124 Argentina Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 125 Argentina Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 126 Argentina Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 127 Argentina Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 128 MEA Multiomics Market, By Country, 2018 - 2030 (USD Million)
- Table 129 MEA Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 130 MEA Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 131 MEA Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 132 MEA Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 133 MEA Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 134 South Africa Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 135 South Africa Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 136 South Africa Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 137 South Africa Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 138 South Africa Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 139 UAE Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 140 UAE Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 141 UAE Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 142 UAE Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 143 UAE Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 144 Saudi Arabia Multiomics Market, By Product & Service, 2018 - 2030 (USD Million),
- Table 145 Saudi Arabia Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 146 Saudi Arabia Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 147 Saudi Arabia Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 148 Saudi Arabia Multiomics Market, By End-use, 2018 - 2030 (USD Million)
- Table 149 Kuwait Multiomics Market, By Product & Service, 2018 - 2030 (USD Million)
- Table 150 Kuwait Multiomics Market, By Type, 2018 - 2030 (USD Million)
- Table 151 Kuwait Multiomics Market, By Platform, 2018 - 2030 (USD Million)
- Table 152 Kuwait Multiomics Market, By Application, 2018 - 2030 (USD Million)
- Table 153 Kuwait Multiomics Market, By End-use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value chain-based sizing & forecasting
- Fig. 6 Market formulation & validation
- Fig. 7 Multiomics market segmentation
- Fig. 8 Market snapshot, 2022
- Fig. 9 Market trends & outlook
- Fig. 10 Market driver relevance analysis (current & future impact)
- Fig. 11 Market restraint relevance analysis (current & future impact)
- Fig. 12 PESTEL analysis
- Fig. 13 Porter's five forces analysis
- Fig. 14 Global multiomics market: Product & Service outlook and key takeaways
- Fig. 15 Global multiomics market: Product & Service movement analysis
- Fig. 16 Global multiomics market, for products, 2018 - 2030 (USD Million)
- Fig. 17 Global multiomics market, for instruments, 2018 - 2030 (USD Million)
- Fig. 18 Global multiomics market, for consumables, 2018 - 2030 (USD Million)
- Fig. 19 Global multiomics market, for software, 2018 - 2030 (USD Million)
- Fig. 20 Global multiomics market, for services, 2018 - 2030 (USD Million)
- Fig. 21 Global multiomics market: Type outlook and key takeaways
- Fig. 22 Global multiomics market: Type movement analysis
- Fig. 23 Global multiomics market, for single- cell multiomics, 2018 - 2030 (USD Million)
- Fig. 24 Global multiomics market, for bulk multiomics, 2018 - 2030 (USD Million)
- Fig. 25 Global multiomics market: Platform outlook and key takeaways
- Fig. 26 Global multiomics market: Platform movement analysis
- Fig. 27 Global multiomics market, for genomics, 2018 - 2030 (USD Million)
- Fig. 28 Global multiomics market, for transcriptomics, 2018 - 2030 (USD Million)
- Fig. 29 Global multiomics market, for proteomics, 2018 - 2030 (USD Million)
- Fig. 30 Global multiomics market, for metabolomics, 2018 - 2030 (USD Million)
- Fig. 31 Global multiomics market, for integrated omics platforms, 2018 - 2030 (USD Million)
- Fig. 32 Global multiomics market: Application outlook and key takeaways
- Fig. 33 Global multiomics market: Application movement analysis
- Fig. 34 Global multiomics market, for cell biology, 2018 - 2030 (USD Million)
- Fig. 35 Global multiomics market, for oncology, 2018 - 2030 (USD Million)
- Fig. 36 Global multiomics market, for neurology, 2018 - 2030 (USD Million)
- Fig. 37 Global multiomics market, for immunology, 2018 - 2030 (USD Million)
- Fig. 38 Global multiomics market: End-use outlook and key takeaways
- Fig. 39 Global multiomics market: End-use movement analysis
- Fig. 40 Global multiomics market, for academic and research institutes, 2018 - 2030 (USD Million)
- Fig. 41 Global multiomics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
- Fig. 42 Global multiomics market, for others, 2018 - 2030 (USD Million)
- Fig. 43 Regional marketplace: Key takeaways
- Fig. 44 Regional outlook, 2022 & 2030
- Fig. 45 Global multiomics market: Region movement analysis
- Fig. 46 North America multiomics market, 2018 - 2030 (USD Million)
- Fig. 47 U.S. multiomics market, 2018 - 2030 (USD Million)
- Fig. 48 Canada multiomics market, 2018 - 2030 (USD Million)
- Fig. 49 Europe multiomics market, 2018 - 2030 (USD Million)
- Fig. 50 Germany multiomics market, 2018 - 2030 (USD Million)
- Fig. 51 UK multiomics market, 2018 - 2030 (USD Million)
- Fig. 52 France multiomics market, 2018 - 2030 (USD Million)
- Fig. 53 Italy multiomics market, 2018 - 2030 (USD Million)
- Fig. 54 Spain multiomics market, 2018 - 2030 (USD Million)
- Fig. 55 Denmark multiomics market, 2018 - 2030 (USD Million)
- Fig. 56 Sweden multiomics market, 2018 - 2030 (USD Million)
- Fig. 57 Norway multiomics market, 2018 - 2030 (USD Million)
- Fig. 58 Asia Pacific multiomics market, 2018 - 2030 (USD Million)
- Fig. 59 Japan multiomics market, 2018 - 2030 (USD Million)
- Fig. 60 China multiomics market, 2018 - 2030 (USD Million)
- Fig. 61 India multiomics market, 2018 - 2030 (USD Million)
- Fig. 62 Australia multiomics market, 2018 - 2030 (USD Million)
- Fig. 63 South Korea multiomics market, 2018 - 2030 (USD Million)
- Fig. 64 Thailand multiomics market, 2018 - 2030 (USD Million)
- Fig. 65 Latin America multiomics market, 2018 - 2030 (USD Million)
- Fig. 66 Brazil multiomics market, 2018 - 2030 (USD Million)
- Fig. 67 Mexico multiomics market, 2018 - 2030 (USD Million)
- Fig. 68 Argentina multiomics market, 2018 - 2030 (USD Million)
- Fig. 69 Middle East and Africa multiomics market, 2018 - 2030 (USD Million)
- Fig. 70 South Africa multiomics market, 2018 - 2030 (USD Million)
- Fig. 71 Saudi Arabia multiomics market, 2018 - 2030 (USD Million)
- Fig. 72 UAE multiomics market, 2018 - 2030 (USD Million)
- Fig. 73 Kuwait multiomics market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-136-5
Multiomics Market Growth & Trends:
The global multiomics market size is expected to reach USD 6.38 billion by 2030, registering a CAGR of 15.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.
With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.
The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets
The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.
Multiomics Market Report Highlights:
- Based on product & service, the product segment dominated the market with a revenue share of 60.5% in 2022, which can be attributed to the rising launches of products such as instruments and software
- Based on type, the bulk multiomics held the largest revenue contributor for the industry. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
- Based on platform, genomics dominated the market with a revenue share of 40.6% in 2022. The growth is attributed to the high number of products available in this segment
- Based on application, the cell biology segment dominated the global industry with a share of 38.8% in 2022. In contrast, the oncology segment is projected to register the highest growth rate during the projected period
- Based on end-use, the academic and research institute segment was the largest revenue contributor for the industry, with a share of 50.7%. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
- North America dominated the global industry in 2022 with a revenue share of 48.45%, owing to the presence of key market players in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Information Analysis
- 1.2.2. Market Platform & Data Visualization
- 1.2.3. Data Validation & Publishing
- 1.3. Research Assumptions
- 1.4. Information Procurement
- 1.4.1. Primary Research
- 1.5. Information or Data Analysis
- 1.6. Market Platform & Validation
- 1.7. Market Model
- 1.8. Global Market: CAGR Calculation
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing demand for single cell omics
- 3.2.1.2. Advancements in omics technology and decreasing costs of omics technologies
- 3.2.1.3. Increasing investments and funding from private and public players
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Challenges in multiomics data integration and data complexity
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Product & Service Business Analysis
- 4.1. Multiomics Market: Product & Service Movement Analysis
- 4.2. Products
- 4.2.1. Products Market, 2018 - 2030 (USD Million)
- 4.2.2. Instruments
- 4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
- 4.2.3. Consumables
- 4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
- 4.2.4. Software
- 4.2.4.1. Software Market, 2018 - 2030 (USD Million)
- 4.3. Services
- 4.3.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Type Business Analysis
- 5.1. Multiomics Market: Type Movement Analysis
- 5.2. Single- Cell Multiomics
- 5.2.1. Single- Cell Multiomics Market, 2018 - 2030 (USD Million)
- 5.3. Bulk Multiomics
- 5.3.1. Bulk Multiomics Market, 2018 - 2030 (USD Million)
Chapter 6. Platform Business Analysis
- 6.1. Multiomics Market: Platform Movement Analysis
- 6.2. Genomics
- 6.2.1. Genomics Market, 2018 - 2030 (USD Million)
- 6.3. Transcriptomics
- 6.3.1. Transcriptomics Market, 2018 - 2030 (USD Million)
- 6.4. Proteomics
- 6.4.1. Proteomics Market, 2018 - 2030 (USD Million)
- 6.5. Metabolomics
- 6.5.1. Metabolomics Market, 2018 - 2030 (USD Million)
- 6.6. Integrated Omics Platforms
- 6.6.1. Integrated Omics Platforms Market, 2018 - 2030 (USD Million)
Chapter 7. Application Business Analysis
- 7.1. Multiomics Market: Application Movement Analysis
- 7.2. Cell Biology
- 7.2.1. Cell Biology Market, 2018 - 2030 (USD Million)
- 7.3. Oncology
- 7.3.1. Oncology Market, 2018 - 2030 (USD Million)
- 7.4. Neurology
- 7.4.1. Neurology Market, 2018 - 2030 (USD Million)
- 7.5. Immunology
- 7.5.1. Immunology Market, 2018 - 2030 (USD Million)
Chapter 8. End-use Business Analysis
- 8.1. Multiomics Market: End-use Movement Analysis
- 8.2. Academic and Research Institutes
- 8.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
- 8.4. Others
- 8.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
- 9.1. Multiomics Market Share By Region, 2022 & 2030
- 9.2. North America
- 9.2.1. North America Multiomics Market, 2018 - 2030 (USD Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Target Disease Prevalence
- 9.2.2.3. Competitive Scenario
- 9.2.2.4. U.S. Multiomics Market, 2018 - 2030 (USD Million)
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Target Disease Prevalence
- 9.2.3.3. Competitive Scenario
- 9.2.3.4. Canada Multiomics Market, 2018 - 2030 (USD Million)
- 9.3. Europe
- 9.3.1. Europe Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.2. UK
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Target Disease Prevalence
- 9.3.2.3. Competitive Scenario
- 9.3.2.4. UK Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.3. Germany
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Target Disease Prevalence
- 9.3.3.3. Competitive Scenario
- 9.3.3.4. Germany Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Target Disease Prevalence
- 9.3.4.3. Competitive Scenario
- 9.3.4.4. France Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Target Disease Prevalence
- 9.3.5.3. Competitive Scenario
- 9.3.5.4. Italy Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Target Disease Prevalence
- 9.3.6.3. Competitive Scenario
- 9.3.6.4. Spain Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.7. Denmark
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Target Disease Prevalence
- 9.3.7.3. Competitive Scenario
- 9.3.7.4. Denmark Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.8. Sweden
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Target Disease Prevalence
- 9.3.8.3. Competitive Scenario
- 9.3.8.4. Sweden Multiomics Market, 2018 - 2030 (USD Million)
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Target Disease Prevalence
- 9.3.9.3. Competitive Scenario
- 9.3.9.4. Norway Multiomics Market, 2018 - 2030 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Multiomics Market, 2018 - 2030 (USD Million)
- 9.4.2. Japan
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Target Disease Prevalence
- 9.4.2.3. Competitive Scenario
- 9.4.2.4. Japan Multiomics Market, 2018 - 2030 (USD Million)
- 9.4.3. China
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Target Disease Prevalence
- 9.4.3.3. Competitive Scenario
- 9.4.3.4. China Multiomics Market, 2018 - 2030 (USD Million)
- 9.4.4. India
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Target Disease Prevalence
- 9.4.4.3. Competitive Scenario
- 9.4.4.4. India Multiomics Market, 2018 - 2030 (USD Million)
- 9.4.5. Australia
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Target Disease Prevalence
- 9.4.5.3. Competitive Scenario
- 9.4.5.4. Australia Multiomics Market, 2018 - 2030 (USD Million)
- 9.4.6. Thailand
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Target Disease Prevalence
- 9.4.6.3. Competitive Scenario
- 9.4.6.4. Thailand Multiomics Market, 2018 - 2030 (USD Million)
- 9.4.7. South Korea
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Target Disease Prevalence
- 9.4.7.3. Competitive Scenario
- 9.4.7.4. South Korea Multiomics Market, 2018 - 2030 (USD Million)
- 9.5. Latin America
- 9.5.1. Latin America Multiomics Market, 2018 - 2030 (USD Million)
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Target Disease Prevalence
- 9.5.2.3. Competitive Scenario
- 9.5.2.4. Brazil Multiomics Market, 2018 - 2030 (USD Million)
- 9.5.3. Mexico
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Target Disease Prevalence
- 9.5.3.3. Competitive Scenario
- 9.5.3.4. Mexico Multiomics Market, 2018 - 2030 (USD Million)
- 9.5.4. Argentina
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Target Disease Prevalence
- 9.5.4.3. Competitive Scenario
- 9.5.4.4. Argentina Multiomics Market, 2018 - 2030 (USD Million)
- 9.6. MEA
- 9.6.1. MEA Multiomics Market, 2018 - 2030 (USD Million)
- 9.6.2. South Africa
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Target Disease Prevalence
- 9.6.2.3. Competitive Scenario
- 9.6.2.4. South Africa Multiomics Market, 2018 - 2030 (USD Million)
- 9.6.3. Saudi Arabia
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Target Disease Prevalence
- 9.6.3.3. Competitive Scenario
- 9.6.3.4. Saudi Arabia Multiomics Market, 2018 - 2030 (USD Million)
- 9.6.4. UAE
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Target Disease Prevalence
- 9.6.4.3. Competitive Scenario
- 9.6.4.4. UAE Multiomics Market, 2018 - 2030 (USD Million)
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Target Disease Prevalence
- 9.6.5.3. Competitive Scenario
- 9.6.5.4. Kuwait Multiomics Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Company Categorization
- 10.2. Strategy Mapping
- 10.3. Company Market Position Analysis, 2022
- 10.4. Company Profiles/Listing
- 10.4.1. BD
- 10.4.1.1. Overview
- 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.1.3. Product Benchmarking
- 10.4.1.4. Strategic Initiatives
- 10.4.2. Thermo Fisher Scientific, Inc,
- 10.4.2.1. Overview
- 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.2.3. Product Benchmarking
- 10.4.2.4. Strategic Initiatives
- 10.4.3. Illumina
- 10.4.3.1. Overview
- 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.3.3. Product Benchmarking
- 10.4.3.4. Strategic Initiatives
- 10.4.4. Danaher
- 10.4.4.1. Overview
- 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.4.3. Product Benchmarking
- 10.4.4.4. Strategic Initiatives
- 10.4.5. PerkinElmer
- 10.4.5.1. Overview
- 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.5.3. Product Benchmarking
- 10.4.5.4. Strategic Initiatives
- 10.4.6. Shimadzu Corporation
- 10.4.6.1. Overview
- 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.6.3. Product Benchmarking
- 10.4.6.4. Strategic Initiatives
- 10.4.7. Bruker
- 10.4.7.1. Overview
- 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.7.3. Product Benchmarking
- 10.4.7.4. Strategic Initiatives
- 10.4.8. QIAGEN
- 10.4.8.1. Overview
- 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.8.3. Product Benchmarking
- 10.4.8.4. Strategic Initiatives
- 10.4.9. Agilent Technologies
- 10.4.9.1. Overview
- 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.9.3. Product Benchmarking
- 10.4.9.4. Strategic Initiatives
- 10.4.10. BGI
- 10.4.10.1. Overview
- 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 10.4.10.3. Product Benchmarking
- 10.4.10.4. Strategic Initiatives
- 10.4.1. BD
